In our case, the triad of sensory neuropathy, pyramidal tract involvement, and posterior column impairment is attributable to AP3B2 expression in the dorsal root ganglia, spinal cord, and cerebral cortex. The gene discussed is AP3B2; the disease is sensory peripheral neuropathy.